SAFETY AND EFFICACY OF UPADACITINIB FOR PEDIATRIC PATIENTS WITH POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS: AN INTERIM ANALYSIS OF AN OPEN-LABEL, PHASE 1 TRIAL

被引:4
|
作者
Brunner, H. [1 ]
Horneff, G. [2 ,3 ]
Foeldvari, I. [4 ]
Anton, J. [5 ]
Mohamed, M. E. [6 ]
Qian, Y. [6 ]
Unnebrink, K. [7 ]
Hao, S. [6 ]
Camp, H. [6 ]
Khan, N. [6 ]
Shmagel, A. [6 ]
机构
[1] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Rheumatol, Cincinnati, OH USA
[2] Asklepios Clin Sankt Augustin, Gen Pediat, St Augustin, Germany
[3] Univ Hosp Cologne, Paediat & Adolescents Med, Cologne, Germany
[4] Klinikum Eilbek, Hamburger Zentrum Kinder & Jugendrheumatol, Hamburg, Germany
[5] Univ Barcelona, Hosp Sant Joan Deu, Pediat Rheumatol, Barcelona, Spain
[6] AbbVie, Rheumatol, N Chicago, IL USA
[7] AbbVie Deutschland GmbH & Co KG, Rheumatol, Ludwigshafen, Germany
关键词
Clinical Trials; Safety; Outcome measures;
D O I
10.1136/annrheumdis-2023-eular.3987
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:108 / 109
页数:2
相关论文
共 50 条
  • [1] PHARMACOKINETICS OF UPADACITINIB IN PEDIATRIC PATIENTS WITH POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS
    Qian, Y.
    Shmagel, A.
    Hao, S.
    Horneff, G.
    Brunner, H.
    Camp, H.
    Liu, W.
    Mohamed, M. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 666 - 667
  • [2] Efficacy and Safety of Tocilizumab for Polyarticular-Course Juvenile Idiopathic Arthritis in the Open-Label Two-Year Extension of a Phase III Trial
    Brunner, Hermine I.
    Ruperto, Nicolino
    Zuber, Zbigniew
    Cuttica, Ruben
    Keltsev, Vladimir
    Xavier, Ricardo M.
    Burgos-Vargas, Ruben
    Penades, Inmaculada Calvo
    Silverman, Earl D.
    Espada, Graciela
    Zavaler, Manuel Ferrandiz
    Kimura, Yukiko
    Duarte, Carolina
    Job-Deslandre, Chantal
    Joos, Rik
    Douglass, Wendy
    Wimalasundera, Sunethra
    Bharucha, Kamal N.
    Wells, Chris
    Lovell, Daniel J.
    Martini, Alberto
    de Benedetti, Fabrizio
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (03) : 530 - 541
  • [3] Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study
    Nicolino Ruperto
    Hermine I. Brunner
    Zbigniew Zuber
    Nikolay Tzaribachev
    Daniel J. Kingsbury
    Ivan Foeldvari
    Gerd Horneff
    Elzbieta Smolewska
    Richard K. Vehe
    Anasuya Hazra
    Rong Wang
    Charles A. Mebus
    Christine Alvey
    Manisha Lamba
    Sriram Krishnaswami
    Thomas C. Stock
    Min Wang
    Ricardo Suehiro
    Alberto Martini
    Daniel J. Lovell
    Pediatric Rheumatology, 15
  • [4] Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study
    Ruperto, Nicolino
    Brunner, Hermine I.
    Zuber, Zbigniew
    Tzaribachev, Nikolay
    Kingsbury, Daniel J.
    Foeldvari, Ivan
    Horneff, Gerd
    Smolewska, Elzbieta
    Vehe, Richard K.
    Hazra, Anasuya
    Wang, Rong
    Mebus, Charles A.
    Alvey, Christine
    Lamba, Manisha
    Krishnaswami, Sriram
    Stock, Thomas C.
    Wang, Min
    Suehiro, Ricardo
    Martini, Alberto
    Lovell, Daniel J.
    PEDIATRIC RHEUMATOLOGY, 2017, 15
  • [5] Open-label phase 3 study of intravenous golimumab in patients with polyarticular juvenile idiopathic arthritis
    Ruperto, Nicolino
    Brunner, Hermine, I
    Pacheco-Tena, Cesar
    Louw, Ingrid
    Vega-Cornejo, Gabriel
    Spindler, Alberto J.
    Kingsbury, Daniel J.
    Schmeling, Heinrike
    Borzutzky, Arturo
    Cuttica, Ruben
    Inman, C. J.
    Malievskiy, Victor
    Scott, Christiaan
    Keltsev, Vladimir
    Terreri, Maria Teresa
    Viola, Diego Oscar
    Xavier, Ricardo M.
    Fernandes, Taciana A. Pedrosa
    Velazquez, Maria Del Rocio Maldonado
    Henrickson, Michael
    Clark, Michael B.
    Bensley, Karen A.
    Li, Xiaoming
    Lo, Kim Hung
    Leu, Jocelyn H.
    Hsu, Chyi-Hung
    Hsia, Elizabeth C.
    Xu, Zhenhua
    Martini, Alberto
    Lovell, Daniel J.
    RHEUMATOLOGY, 2021, 60 (10) : 4495 - 4507
  • [6] Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis Results From a Phase III Open-Label Study
    Brunner, Hermine, I
    Tzaribachev, Nikolay
    Vega-Cornejo, Gabriel
    Louw, Ingrid
    Berman, Alberto
    Calvo Penades, Inmaculada
    Anton, Jordi
    Avila-Zapata, Francisco
    Cuttica, Ruben
    Horneff, Gerd
    Foeldvari, Ivan
    Keltsev, Vladimir
    Kingsbury, Daniel J.
    Oscar Viola, Diego
    Joos, Rik
    Lauwerys, Bernard
    Paz Gastanaga, Maria Eliana
    Elena Rama, Maria
    Wouters, Carine
    Bohnsack, John
    Breedt, Johannes
    Fischbach, Michel
    Lutz, Thomas
    Minden, Kirsten
    Mirava, Tatiana
    Ally, Mahmood M. T. M.
    Rubio-Perez, Nadina
    Gervais, Elisabeth Solau
    Van Zyl, Riana
    Li, Xiaohui
    Nys, Marleen
    Wong, Robert
    Banerjee, Subhashis
    Lovell, Daniel J.
    Martini, Alberto
    Ruperto, Nicolino
    ARTHRITIS & RHEUMATOLOGY, 2018, 70 (07) : 1144 - 1154
  • [7] Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study
    Ryoki Hara
    Hiroaki Umebayashi
    Syuji Takei
    Nami Okamoto
    Naomi Iwata
    Yuichi Yamasaki
    Yasuo Nakagishi
    Toshitaka Kizawa
    Ichiro Kobayashi
    Tomoyuki Imagawa
    Noriko Kinjo
    Norihito Amano
    Yoko Takahashi
    Masaaki Mori
    Yasuhiko Itoh
    Shumpei Yokota
    Pediatric Rheumatology, 17
  • [8] Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study
    Hara, Ryoki
    Umebayashi, Hiroaki
    Takei, Syuji
    Okamoto, Nami
    Iwata, Naomi
    Yamasaki, Yuichi
    Nakagishi, Yasuo
    Kizawa, Toshitaka
    Kobayashi, Ichiro
    Imagawa, Tomoyuki
    Kinjo, Noriko
    Amano, Norihito
    Takahashi, Yoko
    Mori, Masaaki
    Itoh, Yasuhiko
    Yokota, Shumpei
    PEDIATRIC RHEUMATOLOGY, 2019, 17 (1)
  • [9] Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis
    Silverman, E
    Spiegel, L
    Hawkins, D
    Petty, R
    Goldsmith, D
    Schanberg, L
    Duffy, C
    Howard, P
    Strand, V
    ARTHRITIS AND RHEUMATISM, 2005, 52 (02): : 554 - 562
  • [10] EFFICACY AND SAFETY OF TOCILIZUMAB IN PATIENTS WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS: DATA FROM A PHASE 3 TRIAL
    De Benedetti, F.
    Ruperto, N.
    Zuber, Z.
    Keane, C.
    Harari, O.
    Kenwright, A.
    Cuttica, R.
    Keltsev, V.
    Xavier, R.
    Calvo, I.
    Nikishina, I.
    Rubio-Perez, N.
    Alekseeva, E.
    Chasnyk, V.
    Chavez, J.
    Horneff, G.
    Opoka-Winiarska, V.
    Quartier, P.
    Silva, C.
    Silverman, E.
    Spindler, A.
    Martini, A.
    Lovell, D.
    Brunner, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 70 - 70